Story · Public Health · Medicine & Biotech
CVS white paper aims to pressure drugmakers to lower GLP-1 prices
1 outlet · first reported by Healthcare Dive on
GLP-1s would save employers money in the long term if they were priced at $350 a month or less, the pharmacy juggernaut found. “I would love to see this pressure [drugmakers] to bring down prices to something rational,” CMO Amy Compton-Phillips said. (Healthcare Dive)
Coverage, in order
-
CVS white paper aims to pressure drugmakers to lower GLP-1 pricesGLP-1s would save employers money in the long term if they were priced at $350 a month or less, the pharmacy juggernaut found. “I would love to see this pressure [drugmakers] to bring down prices to something rational,” CMO Amy Compton-Phillips said.
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.